Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

Author:  ["Kris Huygen","Jean Content","Olivier Denis","Donna L. Montgomery","Anne M. Yawman","R. Randall Deck","Corrille M. DeWitt","Ian M. Orme","Susan Baldwin","Celine D'Souza","Annie Drowart","Evelyne Lozes","Paul Vandenbussche","Jean-Paul Van Vooren","Margaret A. Liu","Jeffrey B. Ulmer"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

Tuberculosis is the most widespread and lethal infectious disease affecting humans. Immunization of mice with plasmid DNA constructs encoding one of the secreted components of Mycobacterium tuberculosis, antigen 85 (Ag85), induced substantial humoral and cell–mediated immune responses and conferred significant protection against challenge with live M. tuberculosis and M. bovis bacille Calmette–Guérin (BCG). These results indicate that immunization with DNA encoding a mycobacterial antigen provides an efficient and simple method for generating protective immunity and that this technique may be useful for defining the protective antigens of M. tuberculosis, leading to the development of a more effective vaccine.

Cite this article

Huygen, K., Content, J., Denis, O. et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med 2, 893–898 (1996). https://doi.org/10.1038/nm0896-893

View full text

>> Full Text:   Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain norm

Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased